In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

The mRNA Therapeutics market is expanding due to advancements in drug development, personalized medicine, and delivery technologies. Opportunities arise from the technology's success in vaccines and ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

The government has canceled nearly $500 million in research grants into the revolutionary technology, which experts believe ...

Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...

In the same way mRNA COVID-19 vaccines are designed to train the immune system to respond to the spike protein on the surface of SARS-CoV-2, these experimental vaccines focus on the HIV equivalent ...

The first mRNA-based HIV vaccine is about to start human trials The same system Moderna used for its COVID vaccine may also be able to help prevent HIV. Sara Chodosh Aug 18, 2021 11:24 AM EDT ...